Last reviewed · How we verify

NCT05011799

The Peer Genetic Study

Completed NA Last updated 27 January 2026
What this trial tests

NA trial testing Cancer Educational Materials in Healthy Subject in 149 participants. Completed in 28 September 2024.

Timeline
8 January 2020
Primary endpoint
30 June 2023
28 September 2024

Quick facts

Lead sponsorThomas Jefferson University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment149
Start date8 January 2020
Primary completion30 June 2023
Estimated completion28 September 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Thomas Jefferson University

Who can join

Adults 35 to 69, male only, with Healthy Subject or Prostate Carcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This trial studies how well a peer-based health education program works in reducing barriers and changing attitudes and beliefs of prostate cancer genetic screening in African American participants with or without a previous personal or family history of prostate cancer. Participating in a peer-based health educational program may help participants learn more about prostate cancer and how their personal or family history of disease may increase their risk of prostate cancer.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Racial disparity in prostate cancer: an outlook in genetic and molecular landscape.
    Kaushal JB, Raut P, Muniyan S, Siddiqui JA, et al · · 2024 · cited 4× · PMID 38902476 · DOI 10.1007/s10555-024-10193-8

Verify or expand the search:

Other trials of Cancer Educational Materials

Trials testing the same drug.

Other recruiting trials for Healthy Subject

Currently open trials in the same condition.

Other Thomas Jefferson University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05011799.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing